Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  Sientra Inc    SIEN

SIENTRA INC (SIEN)
Mes dernières consult.
Most popular
  Report  
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
02/12/2018 02/13/2018 02/14/2018 02/15/2018 02/16/2018 Date
10.97(c) 10.67(c) 10.85(c) 11.23(c) 11.13(c) Last
168 300 114 150 261 718 212 869 121 083 Volume
-0.09% -2.73% +1.69% +3.50% -0.89% Change
More quotes
Financials ($)
Sales 2017 37,1 M
EBIT 2017 -55,5 M
Net income 2017 -59,7 M
Debt 2017 -
Yield 2017 -
Sales 2018 59,0 M
EBIT 2018 -47,1 M
Net income 2018 -48,4 M
Debt 2018 -
Yield 2018 -
P/E ratio 2017 -
P/E ratio 2018
Capi. / Sales2017 5,88x
Capi. / Sales2018 3,69x
Capitalization 218 M
More Financials
Company
Sientra, Inc. is a medical aesthetics company, which engages in developing and commercializing plastic surgery implantable devices.Its products include breast implants, breast tissue expanders, silicone scar treatment, and additional tissue expanders.The company was founded in 2006 by Hani M. Zeini... 
More about the company
Surperformance© ratings of Sientra Inc
Trading Rating : Investor Rating :
More Ratings
Latest news on SIENTRA INC
02/16Sientra Launches New miraDry fresh™ Protocol for the miraDry® System at..
GL
01/31SIENTRA : Provides Update on FDA Review of U.S. Manufacturing Facility
AQ
01/30Sientra® Provides Update on FDA Review of U.S. Manufacturing Facility
GL
01/25SIENTRA, INC. : Change in Directors or Principal Officers (form 8-K)
AQ
01/25Sientra Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
GL
01/08SIENTRA, INC. : Results of Operations and Financial Condition, Other Events, Fin..
AQ
01/08Sientra Announces Preliminary Unaudited Fourth Quarter 2017 Revenue
GL
2017SIENTRA : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULT..
AQ
2017SIENTRA : reports 3Q loss
AQ
2017SIENTRA, INC. : Results of Operations and Financial Condition, Financial Stateme..
AQ
More news
Sector news : Medical Equipment, Supplies & Distribution - NEC
02/15STRYKER : U.S. Regulators Extend Window for Critical Stroke Treatment
DJ
02/15STRAUMANN : margin outlook takes shine off revenue surge
RE
02/15COLOPLAST A/S : ConvaTec beats low full-year expectations, shares rise
RE
02/07ESSILOR INTERNATIONAL : Makes Changes to Board of Directors
DJ
02/06BECTON DICKINSON AND : Revenue Helped by Life-Sciences -- Earnings Review
DJ
More sector news : Medical Equipment, Supplies & Distribution - NEC
Latest Tweets
02/16Sientra Launches New miraDry fresh™ Protocol for the miraDry® System at Ameri.. 
02/14David Patrick Williams Buys 5,000 Shares of Regis Co. $RGS Stock  
02/13Regis Co. $RGS Director David Patrick Williams Acquires 5,000 Shares  
02/06Lubrizol : Customer, Sientra, Inc., Receives FDA Approval to Manufacture Brea.. 
02/06New Research: Key Drivers of Growth for Vivint Solar, Pain Therapeutics, Sien.. 
More tweets
Qtime:168
News from SeekingAlpha
01/19Midday Gainers / Losers (1/19/2018) 
01/19HEALTHCARE - TOP 5 GAINERS / LOSERS : 00 am (1/19/2018) 
01/19Premarket analyst action - healthcare 
2017Sientra's (SIEN) CEO Jeff Nugent on Q3 2017 Results - Earnings Call Transcrip.. 
2017Sientra misses by $0.05, misses on revenue 
Chart SIENTRA INC
Duration : Period :
Sientra Inc Technical Analysis Chart | SIEN | US82621J1051 | 4-Traders
Technical analysis trends SIENTRA INC
Short TermMid-TermLong Term
TrendsNeutralNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 5
Average target price 16,5 $
Spread / Average Target 47%
EPS Revisions
Managers
NameTitle
Jeffrey M. Nugent Chairman & Chief Executive Officer
Charles Huiner COO, SVP-Corporate Development & Strategy
Patrick F. Williams CFO, Treasurer & Principal Accounting Officer
Rosalyn Cole d’Incelli Vice President-Clinical Operations
Nicholas Simon Lead Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
SIENTRA INC-22.83%210
MEDTRONIC PLC1.37%110 797
BAXTER INTERNATIONAL2.15%35 975
ZIMMER BIOMET HOLDINGS-2.46%23 831
TERUMO CORP2.42%19 820
ALIGN TECHNOLOGY10.87%19 751